VX-864
VX19-864-101
Phase 2 small_molecule completed
Quick answer
VX-864 for Alpha1-Antitrypsin Deficiency is a Phase 2 program (small_molecule) at Vertex Pharmaceuticals (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vertex Pharmaceuticals (Ireland) Limited
- Indication
- Alpha1-Antitrypsin Deficiency
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed